Paulo Fontoura
Paulo Fontoura publishes mostly in Neurology, Molecular Biology and Physiology, on topics such as Alzheimer's disease research and treatments, Multiple Sclerosis Research Studies and Neurogenetic and Muscular Disorders Research.
- World rank
- #222,600 of 7,710,434 ranked researchers
- Rank in Switzerland
- #4,376 of 80,918
- Works
- 152
- Citations
- 14k
- Citations per work
- 93.1
What does Paulo Fontoura research?
Paulo Fontoura's work is mostly in Medicine (32%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else7750.7%
- Health Sciences4932.1%
- Medicine4932.1%
- Life Sciences2617.2%
- 1Neurology12% of their works
- 2Molecular Biology11% of their works
- 3Physiology9% of their works
- 4Immunology6% of their works
- 5Pathology and Forensic Medicine6% of their works
- 6Psychiatry and Mental health5% of their works
Research topics
- Alzheimer's disease research and treatments
- Multiple Sclerosis Research Studies
- Neurogenetic and Muscular Disorders Research
- Parkinson's Disease Mechanisms and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Dementia and Cognitive Impairment Research
- Autism Spectrum Disorder Research
- Neurological disorders and treatments
Which keywords describe Paulo Fontoura's research?
The keywords of their largest research topics: Neurodegeneration, Oxidative Stress, Diagnostic Criteria, Amyloid Hypothesis, Tau Pathology, Parkinson's Disease, Multiple Sclerosis and Neuromyelitis Optica.
- Subthalamic Nucleus
- Genetics
- Mild Cognitive Impairment
- Quality of Life
- a-Synuclein
- Spinal Muscular Atrophy
- Neuromyelitis Optica
- Parkinson's Disease
- Amyloid Hypothesis
- Oxidative Stress
- Neurodegeneration
- Diagnostic Criteria
- Tau Pathology
- Multiple Sclerosis
- SMN1
- Dopaminergic Neurons
- Cost-effectiveness Analysis
- Alzheimer's Disease
- Autism Spectrum Disorders
- Deep Brain Stimulation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Neurodegeneration522 topics
- Oxidative Stress522 topics
- Diagnostic Criteria402 topics
- Amyloid Hypothesis341 topic
- Tau Pathology341 topic
- Parkinson's Disease302 topics
- Multiple Sclerosis221 topic
- Neuromyelitis Optica221 topic
- SMN1191 topic
- Spinal Muscular Atrophy191 topic
- Dopaminergic Neurons181 topic
- a-Synuclein181 topic
- Cost-effectiveness Analysis151 topic
- Quality of Life151 topic
- Alzheimer's Disease141 topic
- Mild Cognitive Impairment141 topic
- Autism Spectrum Disorders131 topic
- Genetics131 topic
- Deep Brain Stimulation121 topic
- Subthalamic Nucleus121 topic
Where does Paulo Fontoura work?
Paulo Fontoura's main affiliation in the publication record is Roche (Switzerland), Switzerland.
How many publications and citations does Paulo Fontoura have?
OpenAlex counts 152 works and 14,152 citations for Paulo Fontoura, an h-index of 42, ranking #222,600 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Paulo Fontoura
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Paulo Fontoura. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.